Hallux valgus Musculoskeletal Diseases
Conditions
Interventions
The researchers will conduct a single-centre case series design with prospectively collected Patient Reported Outcome Measures data and retrospective case note review. Data will be requested from the
to reflect clinical practice, these patients will be included. Finally, patients will not be excluded because of rheumatoid arthritis if HV is still considered the primary pathology. Instead, patients
Sponsors
NHS Tayside
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged over 16 years 2. Undergone first MTPJ arthrodesis for hallux valgus between January 2016 and July 2021
Exclusion criteria
Exclusion criteria: Patients with inadequate operative information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain is measured using the Manchester-Oxford foot questionnaire (MOxFQ) and the EQ-5D-5L questionnaire at baseline, 26, 52 and 104 weeks postoperatively 2. Walking-standing ability is measured using the Manchester-Oxford foot questionnaire (MOxFQ) at baseline, 26, 52 and 104 weeks postoperatively 3. Social interaction is measured using the Manchester-Oxford foot questionnaire (MOxFQ) at baseline, 26, 52 and 104 weeks postoperatively 4. Overall health is measured using the EQ-5D-5L visual analogue score (VAS) at baseline, 26, 52 and 104 weeks postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication rates, including non-union, pain, reoperation, infection and delayed wound healing. This data will be collected at the end of the study period. | — |
Countries
Scotland, United Kingdom
Contacts
Public ContactRebecca Lewis
Outcome results
None listed